DexCom, Inc. DXCM recently unveiled new data for its upcoming G7 15-day continuous glucose monitoring (CGM) sensor at the ...

Dexcom made a significant design change to a component used in its sensors and did not adequately validate the change, ...

Dexcom’s investigational 15-day continuous glucose monitor has a lower mean absolute relative difference than the current ...

Nanowear announced that it entered into a partnership with Dexcom to ingest glucose data from its latest continuous glucose ...

Of the hundreds of millions of people living with diabetes, most liv. Dexcom wants to make sure they have tools to manage it.

Continuous glucose monitors (CGMs) are monitoring devices people with diabetes use. They apply them directly to the skin and ...

Over the past six months, DexCom has been a great trade ... The Growing Market and Innovation in Continuous Glucose Monitoring (CGM) Technology The WHO estimates […] DXCM faces an FDA warning ...

Both stocks should deliver excellent returns to investors patient enough to hold through volatility. Equity markets started ...

Jake Leach caught up with MedTech Dive during the ATTD conference to discuss new data on the company’s glucose monitors and an FDA warning letter.

DexCom DXCM received a warning letter ... Abbott's FreeStyle Libre continuous glucose monitoring system (CGM) has seen significant growth, with sales surpassing $1.8 billion in the fourth quarter ...